Fostair 200/6 inhalation solution

Land: Storbritannien

Språk: engelska

Källa: myHealthbox

Köp det nu

Bipacksedel Bipacksedel (PIL)
25-05-2024
Produktens egenskaper Produktens egenskaper (SPC)
25-05-2024

Aktiva substanser:

beclometasone dipropionate, formoterol fumarate dihydrate.

Tillgänglig från:

Chiesi Limited

ATC-kod:

R03AK08

INN (International namn):

beclometasone dipropionate, formoterol fumarate dihydrate.

Dos:

200/6 micrograms/metered dose

Läkemedelsform:

Pressurised inhalation solution.

Administreringssätt:

inhalation use.

Enheter i paketet:

1 or 2 pressurised container which provides 120 actuations

Receptbelagda typ:

POM - Prescription Only Medicine

Tillverkad av:

Chiesi Farmaceutici

Terapeutisk grupp:

Drugs for obstructive airway diseases; Adrenergics, inhalants

Terapeutiska indikationer:

Fostair is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists. Fostair is indicated in adults.

Bemyndigande status:

Authorised

Tillstånd datum:

2015-12-03

Bipacksedel

                                Package Leaflet: Information for the user
_200/6 MICROGRAMS PER ACTUATION PRESSURISED INHALATION SOLUTION_
_BECLOMETASONE DIPROPIONATE/ FORMOTEROL FUMARATE DIHYDRATE_
For use in adults.
PAG. 1/2
0108000870/01
1
2
3
4
FONTS: MetaPlus
CORPO: 9,5 pt
(5) 
CODICE DI RIFERIMENTO 00783/R
REPARTO:
LINEA: 
CHIESI FARMACEUTICI 
S.P.A.
 - PARMA - ITALIA
VIETATA LA MANOMISSIONE
D.Q.O.C. - UFFICIO GRAFICO
AUTORE: MS/Tipocrom
mail: 
m.sigurani@chiesi.com
(1) DESCRIZIONE MATERIALE
DIMENSIONI FOGLIO STESO
540 x 300 mm
(4) CODICE
0108000870/01
(8) DATA A.A.
05/05/2015
(2) F.TO A.A.
F065
(3) 
N˚ PHARMACODE 864 (COD. A BARRE)
DIMENSIONI FOGLIO FINITO PIEGATO
180 x 38 mm
COLORI DI STAMPA N° 1
FUSTELLA
F.E.FOSTAIR 200/6 MCG MDI CH. LTD
(7) 
Rif. richiesta di codifica del 11/05/2015 - 
(6) 
Motivo: 
- Regolatorio:  Launch new product presentation
- Tecnico:
TOT. PAG. PDF: N. 2
Language: English
BIANCA
NERO+retini
TECHNICAL INFORMATION / INFORMAZIONI TECNICHE
DEFINITIVO:         PDF per il fornitore e per Chiesi Farm. 
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS 
IMPORTANT INFORMATION FOR YOU.
 - Keep this leaflet. You may need to read it again.
 - If you have any further questions, ask your doctor, pharmacist or
nurse.
 - This medicine has been prescribed for you only. Do not pass it on
to others. It may harm them, even if their 
signs of illness are the same as yours.
 - If you get any side effects talk with your doctor, pharmacist or
nurse. This includes any possible side 
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.  What Fostair is and what it is used for
2. What you need to know before you use Fostair
3. How to use Fostair
4. Possible side effects
5. How to store Fostair
6. Contents of the pack and other information
1. WHAT FOSTAIR IS AND WHAT IT IS USED FOR
Fostair is a pressurised inhalation solution containing two active
substances which are inhaled through your 
mouth and delivered directly into
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                )RVWDLULQKDODWLRQVROXWLRQ
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG'HF_&KLHVL/LPLWHG
1DPHRIWKHPHGLFLQDOSURGXFW
)RVWDLUPLFURJUDPVSHUDFWXDWLRQSUHVVXULVHGLQKDODWLRQVROXWLRQ
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKPHWHUHGGRVHH[YDOYHFRQWDLQV
PLFURJUDPVRIEHFORPHWDVRQHGLSURSLRQDWHDQGPLFURJUDPVRIIRUPRWHUROIXPDUDWHGLK\GUDWH7KLVLVHTXLYDOHQW
WRDGHOLYHUHGGRVHH[DFWXDWRURIPLFURJUDPVRIEHFORPHWDVRQHGLSURSLRQDWHDQGPLFURJUDPVRIIRUPRWHURO
IXPDUDWHGLK\GUDWH
)RUWKHIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
3UHVVXULVHGLQKDODWLRQVROXWLRQ
7KHFDQLVWHUFRQWDLQVDFRORXUOHVVWR\HOORZLVKVROXWLRQ
7KHFDQLVWHUVDUHILWWHGLQWRDSODVWLFDFWXDWRULQFRUSRUDWLQJDPRXWKSLHFHDQGILWWHGZLWKDGXVWFDS
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
)RVWDLULVLQGLFDWHGLQWKHUHJXODUWUHDWPHQWRIDVWKPDZKHUHXVHRIDFRPELQDWLRQSURGXFWLQKDOHGFRUWLFRVWHURLGDQG
ORQJDFWLQJEHWD

DJRQLVWLVDSSURSULDWH
SDWLHQWVQRWDGHTXDWHO\FRQWUROOHGZLWKLQKDOHGFRUWLFRVWHURLGVDQG
DVQHHGHG LQKDOHGUDSLGDFWLQJEHWD

DJRQLVWRU
SDWLHQWVDOUHDG\DGHTXDWHO\FRQWUROOHGRQERWKLQKDOHGFRUWLFRVWHURLGVDQGORQJDFWLQJEHWD

DJRQLVWV
)RVWDLULVLQGLFDWHGLQDGXOWV
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
3RVRORJ\
)RVWDLULVQRWLQWHQGHGIRUWKHLQLWLDOPDQDJHPHQWRIDVWKPD7KHGRVDJHRIWKHFRPSRQHQWVRI)RVWDLULVLQGLYLGXDODQG
VKRXOGEHDGMXVWHGWRWKHVHYHULW\RIWKHGLVHDVH7KLVVKRXOGEHFRQVLGHUHGQRWRQO\ZKHQWUHDWPHQWZLWKFRPELQDWLRQ
SURGXFWVLVLQLWLDWHGEXWDOVRZKHQWKHGRVHLVDGMXVWHG,IDQLQGLYLGXDOSDWLHQWVKRXOGUHTXLUHDFRPELQDWLRQRIGRVHV
RWKHUWKDQWKRVHDYDLODEOHLQWKHFRPELQDWLRQLQKDOHUDSSURSULDWHGRVHVRIEHWD

DJRQLVWVDQGRUFRUWLFRVWHURLGVE\
LQGLYLGXDOLQKDOHUVVKRXOGEHSUHVFULEHG
%HFORPHWDVRQHGLSURSLRQDWHLQ)RVWDLULVFKDUDFWHULVHGE\DQH[WUDILQHSDUWLFOHVL]HGLVWULEXWLRQZKLFKUHVXOWVLQDPRUH
SRWHQWHIIHFWWKDQIRUPXODWLRQVRIEHFORPHWDVRQHGLSURSLRQDWHZLW
                                
                                Läs hela dokumentet